At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 13, 2026 at 15:27 ET
Brown Advisory Inc. disclosed a 5.8% passive stake in Bioventus Inc. via Schedule 13G, reporting 3,960,468 shares of Class A Common Stock as of September 30, 2026. This is a new 5%+ filing by Brown Advisory, adding to a prior BlackRock stake that fell below 5% and a Nantahala Capital stake that was previously reported. The filing certifies passive intent with no plan to influence control.
- Brown Advisory Inc. filed a new Schedule 13G for Bioventus Inc. on November 13, 2026
- Reports beneficial ownership of 3,960,468 shares of Class A Common Stock (5.8% of outstanding shares) as of September 30, 2026
- Filing certifies passive intent under Rule 13d-1(b), no purpose of changing or influencing control
- Brown Advisory LLC, a subsidiary, holds 3,743,186 shares (5.72%) directly
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access